SCHEMBL23668359

SCHEMBL23668359

COc1ccc(N(c2ccc(OC)cc2)c2ccc3c(c2)c2cc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)ccc2n3CCP(=O)(O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 4/20 0.42
▸ PTGER4 P35408 1/20 0.40
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ KDM4E B2RXH2 6/20 0.39
▸ MAPT P10636 3/20 0.39
▸ MAOA P21397 2/20 0.38
▸ MAOB P27338 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ GRIK1 P39086 1/20 0.37
▸ GRIK2 Q13002 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30712222 1.00 TSPO (0.42) TSPOPTGER4RAB9AMEN1NPC1
SCHEMBL23668365 0.85 PSEN1 (0.43) TSPOPTGER4RAB9AMEN1NPC1
SCHEMBL22804520 0.85 MAOA (0.50) PTGER4RAB9AMEN1NPC1KMT2A
SCHEMBL29445740 0.85 MAOA (0.50) PTGER4RAB9AMEN1NPC1KMT2A
Alcohol SCHEMBL29276574 0.84 PTGER4 (0.49) TSPOPTGER4RAB9AMEN1NPC1
SCHEMBL26882922 0.84 ALDH1A1 (0.40) TSPOPTGER4MEN1KMT2AKDM4E
SCHEMBL17485884 0.83 MAOA (0.50) TSPOPTGER4MEN1KMT2AKDM4E
SCHEMBL17485896 0.81 MAOA (0.56) TSPOPTGER4MEN1KMT2AKDM4E
SCHEMBL19170247 0.81 MAOA (0.56) TSPOPTGER4MEN1KMT2AKDM4E
SCHEMBL17485888 0.81 MAOA (0.56) TSPOPTGER4MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12207546-B2 Hole-transporting self-organized monolayer for perovskite solar cells HELMHOLTZ-ZENTRUM BERLIN FÜR MATERIALIEN UND ENERGIE GMBH (DE) 2025-01-21 — — US disclosed
US-20240016052-A1 TANDEM PHOTOVOLTAIC DEVICE COMBINING A SILICON-BASED SUB-CELL AND A PEROVSKITE-BASED SUB-CELL INCLUDING AN N-LAYER WITH CONTROLLED CARBON CONTENT 3SUN S.R.L. (IT) 2024-01-11 — — US disclosed
CN-117280886-A Tandem photovoltaic device comprising a combination of a silicon-based subcell and a perovskite-based subcell comprising an N layer having a controlled carbon content 原子能和替代能源委员会 2023-12-22 — — CN disclosed
US-20210234101-A1 HOLE-TRANSPORTING SELF-ORGANISED MONOLAYER FOR PEROVSKITE SOLAR CELLS HELMHOLTZ-ZENTRUM BERLIN FÜR MATERIALIEN UND ENERGIE GMBH (DE) 2021-07-29 — — US disclosed
US-20210234101-A1 HOLE-TRANSPORTING SELF-ORGANISED MONOLAYER FOR PEROVSKITE SOLAR CELLS HELMHOLTZ-ZENTRUM BERLIN FÜR MATERIALIEN UND ENERGIE GMBH (DE) 2021-07-29 — — US disclosed
CN-112469727-A Self-organized monolayer for hole transport of perovskite solar cells 赫姆霍茨中心柏林材料与能源有限公司 2021-03-09 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12207546-B2 Hole-transporting self-organized monolayer for perovskite solar cells SLC43A1, SLCO2A1, SLC6A15 TSPO 36/4885PTGER4 4311/4885RAB9A 2952/4885
US-20210234101-A1 HOLE-TRANSPORTING SELF-ORGANISED MONOLAYER FOR PEROVSKITE SOLAR CELLS SLC43A1, SLCO2A1, HTR1F TSPO 46/4885PTGER4 4476/4885RAB9A 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback